TLDR Erectile dysfunction is linked to marital issues in patients with benign prostatic hyperplasia.
The study explored the link between erectile dysfunction (ED) and marital subsystem functionality in 143 patients with benign prostatic hyperplasia (BPH) treated with tamsulosin and finasteride. It found that 135 patients experienced ED, and 73 had dysfunction in their marital subsystem. Utilizing the IIEF-5 questionnaire and the Chávez-Velasco scale, the study concluded there was a positive association between ED and marital subsystem functionality, with a statistically significant p-value of 0.027.
20 citations
,
August 2018 in “The World Journal of Men's Health” Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.
78 citations
,
December 2008 in “The Journal of Sexual Medicine” 5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.
54 citations
,
October 2019 in “Cochrane library” Some drugs may reduce prostatitis symptoms short-term with few side effects.
3 citations
,
December 2016 in “Sexual medicine reviews” The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.
30 citations
,
September 2016 in “BMJ” Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.
35 citations
,
April 2013 in “Sexual medicine reviews” 5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.
1 citations
,
July 2018 in “Current Sexual Health Reports” Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.
